This company listing is no longer active
Prostatype Genomics (PROGEN BTU) Stock Overview
Manufactures, markets, and sells prognostic gene tests. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
PROGEN BTU Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Join community and earn perks
Prostatype Genomics AB (publ) Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | SEK 0.49 |
| 52 Week High | SEK 0.58 |
| 52 Week Low | SEK 0.39 |
| Beta | 0.33 |
| 1 Month Change | n/a |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -2.40% |
Recent News & Updates
Recent updates
Shareholder Returns
| PROGEN BTU | SE Biotechs | SE Market | |
|---|---|---|---|
| 7D | 8.4% | -1.6% | -1.8% |
| 1Y | n/a | 28.3% | 10.1% |
Return vs Industry: Insufficient data to determine how PROGEN BTU performed against the Swedish Biotechs industry.
Return vs Market: Insufficient data to determine how PROGEN BTU performed against the Swedish Market.
Price Volatility
| PROGEN BTU volatility | |
|---|---|
| PROGEN BTU Average Weekly Movement | n/a |
| Biotechs Industry Average Movement | 9.6% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in SE Market | 12.5% |
| 10% least volatile stocks in SE Market | 3.5% |
Stable Share Price: PROGEN BTU has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine PROGEN BTU's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2007 | 6 | Fredrik Persson | www.prostatypegenomics.com |
Prostatype Genomics AB manufactures, markets, and sells the prognostic gene tests. It offers Prostatype Test System that combines gene expression information with used clinical parameters, such as PSA, Gleason Score, and Tumor Stage, as well as calculates the P-score. The company’s test is based on database containing prostate cancer patients and provides decision support for patients and doctors when making a treatment decision.
Prostatype Genomics AB (publ) Fundamentals Summary
| PROGEN BTU fundamental statistics | |
|---|---|
| Market cap | SEK 21.92m |
| Earnings (TTM) | -SEK 34.04m |
| Revenue (TTM) | SEK 861.45k |
Is PROGEN BTU overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| PROGEN BTU income statement (TTM) | |
|---|---|
| Revenue | SEK 861.45k |
| Cost of Revenue | SEK 15.49m |
| Gross Profit | -SEK 14.63m |
| Other Expenses | SEK 19.41m |
| Earnings | -SEK 34.04m |
Last Reported Earnings
Jun 30, 2023
Next Earnings Date
Feb 15, 2024
| Earnings per share (EPS) | -0.15 |
| Gross Margin | -1,697.85% |
| Net Profit Margin | -3,951.20% |
| Debt/Equity Ratio | 2.3% |
How did PROGEN BTU perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/01/18 22:59 |
| End of Day Share Price | 2024/01/18 00:00 |
| Earnings | 2023/06/30 |
| Annual Earnings | 2022/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Prostatype Genomics AB (publ) is covered by 1 analysts. of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Johan Unnerus | Redeye |